CIHR BIOTECanada/Schering-Plough Canada Fellowship
The CIHR BIOTECanada/Schering-Plough Canada Fellowship honours the leadership CIHR has shown toward the community of health research in Canada. The award is presented to the highest-ranked postdoctoral fellowship candidate in the fields of immunology, infectious and inflammatory diseases, cardiovascular conditions, allergies and respiratory problems.BIOTECanada is dedicated to the sustainable commercial development of biotechnology innovation in Canada. It is the national industry-funded association with almost 200 member companies representing the broad spectrum of biotech constituents including emerging and established companies in the health, agricultural, and industrial sectors, as well as academic and research institutions and other related organizations.
Schering-Plough Canada Inc. is a country operation of Schering-Plough Corporation that employs over 850 people across Canada. Schering-Plough Corporation is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by approximately 33,500 people around the world.
Who is eligible?
Candidates that have been deemed eligible to the CIHR Fellowship program and that have demonstrated a significant achievement in one or more of the following areas: immunology, infectious and inflammatory diseases, cardiovascular conditions, allergies and/or respiratory problems may be eligible for the CIHR BIOTECanada Schering-Plough Canada Fellowship.
Application Procedures
Refer to Fellowship: Fall 2008 Priority Announcement (Specific Research Areas) for general application procedures.
Past Recipients of the CIHR BIOTECanada/Schering-Plough Canada Fellowship
2008
Dr. Etienne Gagnon
2007
Dr. Filio Billia